GRUSF - Grown Rogue Reports First Quarter 2024 Results
Canada NewsWire
- Record quarterly revenue of $6.7M compared to $6.0M in the three months ended April 30, 2023 , an increase of 11%
- Operating Cash Flow (OCF), before changes in working capital (WC), of $1.8M compared to $1.7M in the three months ended April 30, 2023 , a slight increase of 1%
- Free Cash Flow 1 (FCF) of ( $1.9M ), which includes $2.9M in cash advances to the New Jersey partners
- Announced management team update to lead the Company on its next phase of growth
- Construction in New Jersey is substantially on time and on budget with sales expected in H2 2024
- Announced expansion into the Illinois market, with sales expected in H2 2025
MEDFORD, Ore. , May 30, 2024 /CNW/ - Grown Rogue International Inc. ("Grown Rogue" or the "Company") (CSE: GRIN) (OTC: GRUSF), a craft cannabis born from the amazing terroir of Oregon's Rogue Valley, is pleased to report its first quarter 2024 results for the three months ended March 31, 2024 . The comparison period for 2023 is the three months ended April 30, 2023 , due to the recent fiscal year end change from October 31 to December 31 . All financial information is provided in U.S. dollars unless otherwise indicated.
First Quarter 2024 Financial Summary ( Millions)
| First Quarter 2024 Summary |
| 2024 |
| 2023* |
| +/- % |
| Revenue |
| 6.7 |
| 6.0 |
| +11 % |
| aEBITDA |
| 2.4 |
| 2.1 |
| +16 % |
| aEBITDA % |
| 36.9 % |
| 35.1 % |
| +180 bps |
| OCF (Before Changes in WC ) |
| 1.8 |
| 1.7 |
| +1 % |
| OCF % |
| 26.5 % |
| 29.1 % |
| -260 bps |
| *2023 data is February-April due to the fiscal year end change |
"This was another exciting quarter with record revenue and aEBITDA despite the year ago comparison period including April instead of January; April is seasonally a stronger month for the industry. In addition, we achieved record indoor revenue in Michigan and Oregon during the quarter and are thrilled that an increasing number of customers in competitive markets are choosing our products which means we are continuing to bring them value," said Obie Strickler , CEO of Grown Rogue.
"We completed a management enhancement in January, that bolstered our team across cultivation, post-harvest, finance, and accounting; to prepare for the significant growth that is in front of us. This included both internal and external talent and I'm particularly pleased with our ability to develop our internal team to take on greater responsibility and provide the foundation for new external talent to immediately contribute to our success. Thus far, we are thrilled with the performance of our entire team as we support our entry into new markets.
Our primary growth drivers in 2024 and 2025 continue to be our expansion efforts in New Jersey and Illinois . The construction of New Jersey Phase I is substantially on time and on budget and we continue to expect sales to New Jerseyans in the back half of this year. Grown Rogue recently obtained initial state licensing approval in New Jersey and will share additional information on that shortly. Illinois design and engineering is underway, and we are targeting sales starting in the second half of 2025," continued Mr. Strickler.
"The recent early warrant exercise shows the commitment and alignment of our shareholders to our strategy and has capitalized the Company to execute on the current growth initiatives in New Jersey and Illinois. Our plan for expansion projects remains one to two new markets per year as we roll out our national expansion strategy. We strongly believe that high quality, low cost cannabis cultivation, that delights our customers, is a protectable moat that sets us up for continued growth in new markets.
I want to personally thank all of our customers, the entire Grown Rogue team, and our shareholders each doing their part to help Grown Rogue achieve our goal of becoming the first nationally recognized craft cannabis company in the U.S."
Oregon Market Highlights ( Millions)
| Oregon |
| 2024 |
| 2023* |
| +/- % |
| Revenue |
| 3.1 |
| 2.9 |
| +5 % |
| aEBITDA |
| 1.2 |
| 1.1 |
| +9 % |
| aEBITDA Margin %
|
| 38.2 % |
| 36.9 % |
| +130 bps |
| * 2023 data is February-April |
Michigan Market Highlights ( Millions)
| Michigan |
| 2024 |
| 2023* |
| +/- % |
| Revenue |
| 3.2 |
| 2.8 |
| +14 % |
| aEBITDA |
| 1.4 |
| 1.3 |
| +8 % |
| aEBITDA Margin %
|
| 43.4 % |
| 45.8 % |
| -240 bps |
| *2023 data is February-April |
Michigan operations are through Golden Harvests, LLC.
Financial Statements and aEBITDA reconciliation
| CONSOLIDATED STATEMENTS OF FINANCIAL POSITION |
| March 31, 2024 |
| December 31, 2023 |
| |
| $ |
| $ |
| ASSETS |
| |
| |
| Current assets |
| |
| |
| Cash and cash equivalents |
| 9,453,084 |
| 6,804,579 |
| Accounts receivable (Note 18) |
| 1,985,253 |
| 1,642,990 |
| Biological assets (Note 3) |
| 1,805,576 |
| 1,723,342 |
| Inventory (Note 4) |
| 4,883,654 |
| 5,021,290 |
| Prepaid expenses and other assets |
| 1,652,639 |
| 420,336 |
| Notes receivable |
| 264,333 |
| - |
| Total current assets |
| 20,044,539 |
| 15,612,537 |
| Property and equipment (Note 8) |
| 9,908,337 |
| 8,820,897 |
| Notes receivable (Notes 6.2.1, 6.2.2 and 6.2.3) |
| 4,631,227 |
| 2,449,122 |
| Warrants asset (Note 13.2) |
| 3,054,229 |
| 1,761,382 |
| Intangible assets and goodwill (Note 9) |
| 725,668 |
| 725,668 |
| Deferred tax asset (Note 20) |
| 339,545 |
| 246,294 |
| TOTAL ASSETS |
| 38,703,545 |
| 29,615,900 |
| LIABILITIES |
| |
| |
| Current liabilities |
| |
| |
| Accounts payable and accrued liabilities |
| 1,706,864 |
| 1,358,962 |
| Current portion of lease liabilities (Note 7) |
| 741,086 |
| 925,976 |
| Current portion of long-term debt (Note 10) |
| 838,332 |
| 780,358 |
| Business acquisition consideration payable (Note 5) |
| 360,000 |
| 360,000 |
| Derivative liability (Notes 11.1 and 11.2) |
| 12,542,215 |
| 7,471,519 |
| Income tax payable |
| 1,060,386 |
| 873,388 |
| Convertible debentures (Notes 11.1 and 11.2) |
| 2,468,252 |
| - |
| Total current liabilities |
| 19,717,135 |
| 11,770,203 |
| Lease liabilities (Note 7) |
| 1,850,337 |
| 1,972,082 |
| Long-term debt (Note 10) |
| 1,778,922 |
| 82,346 |
| Convertible debentures (Notes 11.1 and 11.2) |
| - |
| 2,459,924 |
| TOTAL LIABILITIES |
| 23,346,394 |
| 16,284,555 |
| EQUITY |
| |
| |
| Share capital (Note 12) |
| 28,309,071 |
| 24,593,422 |
| Shares issuable (Note 12.5) |
| 1,822,412 |
| - |
| Contributed surplus (Notes 13 and 14) |
| 8,242,482 |
| 8,186,297 |
| Accumulated other comprehensive loss |
| (110,809) |
| (108,069) |
| Accumulated deficit |
| (24,550,057) |
| (20,353,629) |
| Equity attributable to shareholders |
| 13,713,099 |
| 12,318,021 |
| Non-controlling interests (Note 23) |
| 1,644,052 |
| 1,013,324 |
| TOTAL EQUITY |
| 15,357,151 |
| 13,331,345 |
| TOTAL LIABILITIES AND EQUITY |
| 38,703,545 |
| 29,615,900 |
| |
| Three months |
| Three months |
| CONSOLIDATED STATEMENTS OF INCOME & LOSS |
| March 31, 2024 |
| April 30, 2023 |
| AND COMPREHENSIVE INCOME & LOSS |
| $ |
| $ |
| Revenue |
| |
| |
| Product sales |
| 6,271,304 |
| 5,733,497 |
| Service revenue |
| 383,170 |
| 271,140 |
| Total revenue |
| 6,654,474 |
| 6,004,637 |
| Cost of goods sold |
| |
| |
| Cost of finished cannabis inventory sold |
| (2,772,685) |
| (3,064,557) |
| Costs of service revenue |
| (100,069) |
| (125,424) |
| Gross profit, excluding fair value items |
| 3,781,720 |
| 2,814,656 |
| Realized fair value loss amounts in inventory sold |
| (927,479) |
| (637,063) |
| Unrealized fair value gain amounts on growth of biological assets |
| 403,414 |
| 419,874 |
| Gross profit |
| 3,257,655 |
| 2,597,467 |
| Expenses |
| |
| |
| Accretion expense |
| 381,663 |
| 199,773 |
| Amortization of property and equipment (Note 8) |
| 255,052 |
| 67,820 |
| General and administrative (Note 19) |
| 2,019,324 |
| 1,407,521 |
| Share option expense |
| 56,185 |
| 95,563 |
| Total expenses |
| 2,712,224 |
| 1,770,677 |
| Income from operations |
| 545,431 |
| 826,790 |
| Other income and (expense) |
| |
| |
| Interest expense |
| (89,687) |
| (94,063) |
| Other income (expense) |
| 118,450 |
| 169,923 |
| Unrealized gain (loss) on derivative liability |
| (5,660,040) |
| (270,712) |
| Unrealized gain on warrants asset |
| 1,292,848 |
| - |
| Loss on disposal of property and equipment |
| (2,177) |
| - |
| Total other income (expense), net |
| (4,340,606) |
| (194,852) |
| Gain (loss) from operations before taxes |
| (3,795,175) |
| 631,938 |
| Income tax (Note 20) |
| (370,525) |
| (219,959) |
| Net income (loss) |
| (4,165,700) |
| 411,979 |
| Other comprehensive income (items that may be |
| |
| |
| Currency translation gain (loss) |
| (2,740) |
| (1,888) |
| Total comprehensive income (loss) |
| (4,168,440) |
| 410,091 |
| Gain (loss) per share attributable to owners of the parent – basic |
| (0.02) |
| 0.00 |
| Weighted average shares outstanding – basic |
| 183,184,310 |
| 170,832,611 |
| Gain (loss) per share attributable to owners of the parent – diluted |
| 0.01 |
| 0.00 |
| Weighted average shares outstanding – diluted |
| 214,046,728 |
| 170,832,611 |
| Net income (loss) for the period attributable to: |
| |
| |
| Non-controlling interest |
| 30,728 |
| (867) |
| Shareholders |
| (4,196,428) |
| 412,846 |
| Net income (loss) |
| (4,165,700) |
| 411,979 |
| Comprehensive income (loss) for the period attributable to: |
| |
| |
| Non-controlling interest |
| 30,728 |
| (867) |
| Shareholders |
| (4,199,168) |
| 410,958 |
| Total comprehensive income (loss) |
| (4,168,440) |
| 410,091 |
| CONSOLIDATED STATEMENTS OF CASH FLOWS
|
| Three months |
| Three months |
| |
| March 31, 2024 |
| April 30, 2023 |
| |
| $ |
| $ |
| Operating activities |
| |
| |
| Net income (loss) |
| (4,165,700) |
| 411,979 |
| Adjustments for non-cash items in net income (loss): |
| |
| |
| Amortization of property and equipment |
| 255,052 |
| 67,820 |
| Amortization of property and equipment included in costs |
| 439,632 |
| 484,032 |
| Unrealized fair value gain amounts on growth of biological |
| (403,414) |
| (419,874) |
| Realized fair value loss amounts in inventory sold |
| 927,479 |
| 637,063 |
| Deferred income taxes |
| (93,251) |
| - |
| Share option expense |
| 56,185 |
| 95,563 |
| Accretion expense |
| 381,663 |
| 199,773 |
| Loss on disposal of property and equipment |
| 2,177 |
| 168,144 |
| Unrealized loss on fair value of derivative liability |
| 5,660,040 |
| 270,712 |
| Unrealized gain on warrants asset |
| (1,292,847) |
| - |
| Currency translation loss |
| (2,740) |
| (1,891) |
| |
| 1,764,275 |
| 1,745,177 |
| Changes in non-cash working capital (Note 15) |
| (422,527) |
| (284,131) |
| Net cash provided by operating activities |
| 1,341,748 |
| 1,461,046 |
| |
| |
| |
| Investing activities |
| |
| |
| Purchase of property and equipment and intangibles |
| (297,314) |
| (428,955) |
| Cash advances and loans made to other parties |
| (2,947,998) |
| - |
| Net cash used in investing activities |
| (3,245,312) |
| (428,955) |
| |
| |
| |
| Financing activities |
| |
| |
| Proceeds from convertible debentures |
| - |
| 2,000,000 |
| Proceeds from warrants exercises |
| 4,657,460 |
| - |
| Proceeds from options exercises |
| 168,183 |
| - |
| Proceeds from sale of membership units of subsidiary |
| 600,000 |
| - |
| Repayment of long-term debt |
| (284,406) |
| (420,730) |
| Repayment of convertible debentures |
| (141,478) |
| (15,000) |
| Payments of lease principal |
| (447,690) |
| (487,973) |
| Net cash provided by (used in) financing activities |
| 4,552,069 |
| (731,322) |
| |
| |
| |
| Change in cash and cash equivalents |
| 2,648,505 |
| 300,769 |
| Cash and cash equivalents, beginning |
| 6,804,579 |
| 3,488,046 |
| Cash and cash equivalents, ending |
| 9,453,084 |
| 3,788,815 |
| SEGMENTED aEBITDA
|
| 3 months ended March 31, 2024 |
| |
| Oregon |
| Michigan |
| Services |
| Corporate |
| Consolidated |
| Revenue |
| 3,054,223 |
| 3,217,081 |
| 383,170 |
| - |
| 6,654,474 |
| Costs of revenue, excluding fair value |
| (1,533,479) |
| (1,239,206) |
| (100,069) |
| - |
| (2,872,754) |
| Gross profit (loss) before fair value |
| 1,520,744 |
| 1,977,875 |
| 283,101 |
| - |
| 3,781,720 |
| Net fair value adjustments |
| (325,609) |
| (198,456) |
| - |
| |
| (524,065) |
| Gross profit |
| 1,195,135 |
| 1,779,419 |
| 283,101 |
| - |
| 3,257,655 |
| Operating expenses: |
| |
| |
| |
| |
| |
| General and administration |
| 624,820 |
| 750,327 |
| - |
| 644,177 |
| 2,019,324 |
| Depreciation and amortization |
| 28,713 |
| 204,112 |
| - |
| 22,227 |
| 255,052 |
| Share based compensation |
| - |
| - |
| - |
| 56,185 |
| 56,185 |
| Other income and expense: |
| |
| |
| |
| |
| |
| Interest and accretion |
| (134,394) |
| (27,315) |
| - |
| (309,641) |
| (471,350) |
| Loss on disposal or property and |
| (2,177) |
| - |
| - |
| - |
| (2,177) |
| Unrealized (loss) gain on derivative |
| - |
| - |
| - |
| (5,660,040) |
| (5,660,040) |
| Unrealized (loss) gain on warrants |
| - |
| - |
| - |
| 1,292,848 |
| 1,292,848 |
| Other income and expense |
| 190 |
| - |
| - |
| 118,260 |
| 118,450 |
| Net income (loss) before tax |
| 405,221 |
| 797,665 |
| 283,101 |
| (5,281,162) |
| (3,795,175) |
| Tax |
| 9 |
| 401,991 |
| - |
| (31,476) |
| 370,525 |
| Net income after tax |
| 405,212 |
| 395,674 |
| 283,101 |
| (5,249,686) |
| (4,165,700) |
| |
| |
| |
| |
| |
| |
| EBITDA |
| Oregon |
| Michigan |
| Services |
| Corporate |
| Consolidated |
| Net FV adjs |
| 325,609 |
| 198,456 |
| |
| |
| 524,065 |
| Depreciation in COGS |
| 270,403 |
| 169,228 |
| |
| |
| 439,631 |
| Depreciation expense |
| 28,713 |
| 204,111 |
| |
| 22,228 |
| 255,052 |
| Share comp |
| - |
| - |
| - |
| 56,185 |
| 56,185 |
| Unrealized derivative |
| - |
| - |
| - |
| 5,660,040 |
| 5,660,040 |
| Loss on disposal of property plant and |
| 2,177 |
| - |
| - |
| |
| 2,177 |
| Unrealized warrants asset |
| - |
| - |
| - |
| (1,292,848) |
| (1,292,848) |
| Interest and accretion |
| 134,394 |
| 27,314 |
| - |
| 309,642 |
| 471,350 |
| Income tax |
| 9 |
| 401,992 |
| - |
| (31,476) |
| 370,525 |
| EBITDA before one-time adjs |
| 1,166,517 |
| 1,396,775 |
| 283,101 |
| (525,915) |
| 2,320,477 |
| Add back to EBITDA: |
| |
| |
| |
| |
| |
| Costs associated with acquisition of |
| |
| |
| |
| 60,000 |
| 60,000 |
| New production location startup costs |
| |
| |
| |
| 77,314 |
| 77,314 |
| aEBITDA |
| 1,166,517 |
| 1,396,775 |
| 283,101 |
| (388,601) |
| 2,457,791 |
| Adjusted EBITDA margin % |
| 38.2 % |
| 43.4 % |
| 73.9 % |
| |
| 36.9 % |
NOTES:
| 1 The Company's "Free cash flow" metric is defined by cash flow from operations minus capital expenditures and expansion related advances |
| 2 The Company's "aEBITDA," or "Adjusted EBITDA," is a non-IFRS measure used by management that does not have any prescribed meaning by IFRS and that may not be comparable to similar measures presented by other companies. The Company defines "EBITDA" as the Company's net income or loss for a period, as reported, before interest, taxes, depreciation and amortization, and is further adjusted to remove transaction costs, stock-based compensation expense, accretion expense, gain (loss) on derecognition of derivative liabilities, the effects of fair-value accounting for biological assets and inventory, as well as other non-cash items and items not representative of operational performance as reported in net income (loss). Adjusted EBITDA is defined as EBITDA adjusted for the impact of various significant or unusual transactions. The Company believes that this is a useful metric to evaluate its operating performance. |
NON-IFRS FINANCIAL MEASURES
EBITDA and aEBITDA are non-IFRS measures and do not have standardized definitions under IFRS. The Company has also provided unaudited pro-forma financial information, which assumes that closed and pending mergers and acquisitions in 2021 are included in the Company's financial results as of the beginning of the quarterly and annual periods in 2021. The Company has provided the non-IFRS financial measures, which are not calculated or presented in accordance with IFRS, as supplemental information and in addition to the financial measures that are calculated and presented in accordance with IFRS. These supplemental non-IFRS financial measures are presented because management has evaluated the financial results both including and excluding the adjusted items and believe that the supplemental non-IFRS financial measures presented provide additional perspective and insights when analyzing the core operating performance of the business. These supplemental non-IFRS financial measures should not be considered superior to, as a substitute for or as an alternative to, and should only be considered in conjunction with, the IFRS financial measures presented herein. Accordingly, the following information provides reconciliations of the supplemental non-IFRS financial measures, presented herein to the most directly comparable financial measures calculated and presented in accordance with IFRS.
Grown Rogue International Inc. (CSE: GRIN | OTC: GRUSF) is a craft cannabis company operating in Oregon , Michigan , Minnesota , Maryland , and New Jersey , focused on delighting customers with premium flower and flower-derived products at fair prices. The Company's roots are in Southern Oregon , where it has proven its capabilities in the highly competitive and discerning Oregon market. The Company's passion for quality product and value, combined with a disciplined approach to growth, prioritizes profitability and return on capital without sacrificing quality. The Company's strategy is to pursue capital efficient methods to expand into new markets, bringing craft-quality product at fair prices to more consumers. The Company also continues to make modest investments to improve outdoor craft cultivation capabilities in preparation for eventual interstate commerce. For more information, visit www.grownrogue.com .
This press release contains statements which constitute "forward?looking information" within the meaning of applicable securities laws, including statements regarding the plans, intentions, beliefs and current expectations of the Company with respect to future business activities. Forward? looking information is often identified by the words "may," "would," "could," "should," "will," "intend," "plan," "anticipate," "believe," "estimate," "expect" or similar expressions and include information regarding: (i) statements regarding the future direction of the Company (ii) the ability of the Company to successfully achieve its business and financial objectives, (iii) plans for expansion of the Company and securing applicable regulatory approvals, and (iv) expectations for other economic, business, and/or competitive factors. Investors are cautioned that forward?looking information is not based on historical facts but instead reflect the Company's management's expectations, estimates or projections concerning the business of the Company's future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although the Company believes that the expectations reflected in such forward?looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance or achievements of the combined company. Among the key factors that could cause actual results to differ materially from those projected in the forward?looking information are the following: changes in general economic, business and political conditions, including changes in the financial markets; and in particular in the ability of the Company to raise debt and equity capital in the amounts and at the costs that it expects; adverse changes in the public perception of cannabis; decreases in the prevailing prices for cannabis and cannabis products in the markets that the Company operates in; adverse changes in applicable laws; or adverse changes in the application or enforcement of current laws; compliance with extensive government regulation and related costs, and other risks described in the Company's public disclosure documents filed on Sedar.
Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward?looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although the Company has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. The Company does not intend, and does not assume any obligation, to update this forward?looking information except as otherwise required by applicable law.
The Company is indirectly involved in the manufacture, possession, use, sale and distribution of cannabis in the recreational cannabis marketplace in the United States through its indirect operating subsidiaries. Local state laws where its subsidiaries operate permit such activities however, these activities are currently illegal under United States federal law. Additional information regarding this and other risks and uncertainties relating to the Company's business are disclosed in the Company's Listing Statement filed on its issuer profile on SEDAR+ at www.sedarplus.ca . Should one or more of these risks, uncertainties or other factors materialize, or should assumptions underlying the forward-looking information or forward-looking statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected.
No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.
For further information on Grown Rogue, please visit www.grownrogue.com.
SOURCE Grown Rogue International Inc.
View original content: http://www.newswire.ca/en/releases/archive/May2024/30/c3101.html
| Company Name: | Grown Rogue International Inc |
| Stock Symbol: | GRUSF |
| Market: | OTC |
News, Short Squeeze, Breakout and More Instantly...
Market Wire News is a media platform, the information on this page was provided by Canada Newswire via Quote Media. Read our full disclaimer.